CC
Commodore Capital Portfolio holdings
AUM
$1.42B
This Quarter Return
+19.58%
1 Year Return
+73.3%
3 Year Return
+1,330.82%
5 Year Return
–
10 Year Return
–
AUM
$856M
AUM Growth
+$856M
(-3.9%)
Cap. Flow
+$82.2K
Cap. Flow
% of AUM
0.01%
Top 10 Holdings %
Top 10 Hldgs %
65.11%
Holding
33
New
7
Increased
9
Reduced
4
Closed
3
Top Buys
| 1 |
Rhythm Pharmaceuticals
RYTM
|
$47.6M |
| 2 |
Soleno Therapeutics
SLNO
|
$26.2M |
| 3 |
Crinetics Pharmaceuticals
CRNX
|
$14.9M |
| 4 |
Merus
MRUS
|
$10.1M |
| 5 |
VistaGen Therapeutics
VTGN
|
$8.25M |
Top Sells
| 1 |
Akero Therapeutics
AKRO
|
$56.1M |
| 2 |
Spyre Therapeutics
SYRE
|
$34.2M |
| 3 |
CBAY
Cymabay Therapeutics
CBAY
|
$22.2M |
| 4 |
Arrowhead Research
ARWR
|
$21.8M |
| 5 |
Nuvalent
NUVL
|
$14.8M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Merus
MRUS
$4.98B
| $104M | 12.2% | 4,428,072 +428,072 | +11% | +$10.1M |
|
2
Vera Therapeutics
VERA
$1.38B
| $74.7M | 8.73% | 5,450,000 | – | – |
|
3
Xenon Pharmaceuticals
XENE
$2.98B
| $63M | 7.37% | 1,845,000 | – | – |
|
4
Vaxcyte
PCVX
$4B
| $56.1M | 6.55% | 1,100,000 +85,000 | +8% | +$4.33M |
|
5
Cogent Biosciences
COGT
$1.69B
| $54.3M | 6.34% | 5,566,026 | – | – |
|
|
6
Rhythm Pharmaceuticals
RYTM
$6.85B
| $47.6M | 5.56% | +2,075,000 | New | +$47.6M |
|
|
AMAM
7
DELISTED
Ambrx Biopharma, Inc. Common Stock
AMAM
| $40.5M | 4.73% | 3,518,556 +343,556 | +11% | +$3.95M |
|
8
Enliven Therapeutics
ELVN
$1.2B
| $39.6M | 4.63% | 2,901,816 +553,544 | +24% | +$7.56M |
|
9
Cabaletta Bio
CABA
$133M
| $38.4M | 4.49% | 2,525,753 +157,567 | +7% | +$2.4M |
|
10
Immunovant
IMVT
$2.56B
| $38.4M | 4.49% | 1,000,000 +100,000 | +11% | +$3.84M |
|
|
11
Nuvalent
NUVL
$5.52B
| $38.1M | 4.45% | 828,778 -321,222 | -28% | -$14.8M |
|
12
Viridian Therapeutics
VRDN
$1.5B
| $33.7M | 3.94% | 2,200,000 | – | – |
|
|
13
Akero Therapeutics
AKRO
$3.74B
| $28.6M | 3.34% | 565,000 -1,110,000 | -66% | -$56.1M |
|
|
14
Soleno Therapeutics
SLNO
$3.6B
| $26.2M | 3.06% | +887,500 | New | +$26.2M |
|
15
IDEAYA Biosciences
IDYA
$2.15B
| $20.9M | 2.44% | 775,000 | – | – |
|
16
Celldex Therapeutics
CLDX
$1.47B
| $19.4M | 2.27% | 706,665 +75,000 | +12% | +$2.06M |
|
17
Celcuity
CELC
$2.17B
| $15.5M | 1.81% | 1,694,141 +250,000 | +17% | +$2.29M |
|
|
ALPN
18
DELISTED
Alpine Immune Sciences, Inc. Common Stock
ALPN
| $15.2M | 1.77% | 1,325,000 | – | – |
|
19
Adverum Biotechnologies
ADVM
$64.6M
| $15M | 1.75% | 10,000,000 | – | – |
|
|
20
Crinetics Pharmaceuticals
CRNX
$2.92B
| $14.9M | 1.74% | +500,000 | New | +$14.9M |
|
21
Syndax Pharmaceuticals
SNDX
$1.41B
| $13.9M | 1.63% | 957,509 -40,087 | -4% | -$582K |
|
22
Kura Oncology
KURA
$686M
| $12.8M | 1.49% | 1,400,000 | – | – |
|
|
THRD
23
DELISTED
Third Harmonic Bio
THRD
| $10.9M | 1.27% | 1,700,000 +706,706 | +71% | +$4.52M |
|
24
Day One Biopharmaceuticals
DAWN
$769M
| $9.08M | 1.06% | 739,661 | – | – |
|
|
25
VistaGen Therapeutics
VTGN
$102M
| $8.25M | 0.96% | +1,575,000 | New | +$8.25M |
|